2019: A Clear Ambition
Founded in 2019, our microalgae biotechnology platform set out with a clear ambition. Specifically, we aimed to engineer viable biological alternatives. Furthermore, these alternatives needed to outperform traditional production systems. Accordingly, our first offensive targeted alternative proteins. Consequently, we developed these under a rigorously sustainable, accountable framework.
2021: Structuring Our Processes
Soon after, we identified microalgae as a category with exceptional potential. Indeed, this potential remained largely underexploited. Rich in bioactive compounds, these organisms unlocked high-value applications. Specifically, they opened doors across aquaculture, hatchery, and livestock markets. By 2021, consequently, we structured our advanced extraction and stabilization processes. As a result, we successfully delivered standardized, reliable biomolecules. Ultimately, these were engineered for commercial-grade reproducibility.
2022: A Technological Milestone
Then, in 2022, we reached a decisive milestone. Specifically, we rapidly deployed pilot-scale bioreactors and photobioreactors. This infrastructure, in turn, gave us full command over quality and reproducibility. Moreover, it gave us strict control over compound concentration. Ultimately, it seamlessly integrated our entire cultivation and formulation value chain.
Sharpening Our Strategy
These advances, moreover, cemented our scientific positioning. Specifically, they sharpened our strategy toward targeted, high-precision ingredients. Furthermore, these premium ingredients carry tightly controlled biochemical profiles. Since then, our commercial portfolio has expanded significantly. It now covers rotifer enrichment, larval survival, and early-stage development. Additionally, it covers immune support and feed conversion optimization. Indeed, these represent high-margin categories where science-backed performance drives value.
Today: A Fully Integrated Platform
Today, Pholoho Biotechnology operates as a fully integrated microalgae biotechnology platform. Specifically, this means combining a proprietary strain bank with high-yield cultivation. It also means operating a dedicated purification laboratory with in-house formulation expertise. Additionally, we work in close partnership with researchers, hatchery operators, and industry leaders. Together, we consistently deliver both scientific rigor and proven efficacy.
Our Guiding Principle
In response to escalating aquaculture productivity demands, furthermore, we hold firm. Similarly, vital sustainability imperatives heavily guide our operations. Consequently, Pholoho holds to one completely non-negotiable principle. Namely, we ensure rigorous scientific control, measurable quality, and responsible, scalable production.
A Global Vision
This vision, ultimately, now powers a trademark active in more than 40 countries. Furthermore, it backs a premium portfolio of microalgae-derived feed and nutrition products. Specifically, these products are engineered to maximize hatchery yields and livestock performance. Ultimately, they drive vital operational ROI for our industry partners worldwide.
